To include your compound in the COVID-19 Resource Center, submit it here.

Squalamine: Phase IIa

Interim results from MAGN's open label Phase IIa trial of squalamine

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE